The mechanisms linking mild behavioral impairment (MBI) and Alzheimer's disease (AD) have been insufficiently explored, with conflicting results regarding tau protein and few data on other metabolic markers. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.